Fabtech Technologies Ltd

Fabtech Tech. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fabtech Technologies Ltd

₹ 239 -0.99%
12 Dec - close price
fabtechnologies.com BSE: 544558 NSE: FABTECH
About

Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.[1]

Key Points

Business Profile[1]
Fabtech provides end-to-end turnkey pharma plant solutions covering design, engineering, procurement, installation, and regulatory validation, while also offering standalone execution services like equipment supply and installation for clients with their own designs.

Website BSE NSE
  • Market Cap ₹ 1,062 Cr.
  • Current Price ₹ 239
  • High / Low ₹ 263 / 173
  • Stock P/E 19.4
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 22.0 %
  • ROE 20.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 23.6%

Cons

  • Earnings include an other income of Rs.27.4 Cr.
  • Company has high debtors of 168 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Research, Analytics & Technology

Part of BSE IPO

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2024 Jun 2025 Sep 2025
59 68 121
54 74 91
Operating Profit 5 -6 30
OPM % 8% -9% 25%
2 3 3
Interest 0 1 1
Depreciation 1 1 1
Profit before tax 6 -6 31
Tax % 15% -1% 10%
5 -6 28
EPS in Rs 1.58 -1.89 8.68
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
133 121 257 194 226 327
119 110 225 169 191 288
Operating Profit 14 11 32 25 35 39
OPM % 11% 9% 12% 13% 15% 12%
5 2 4 10 6 27
Interest 2 2 3 5 3 3
Depreciation 0 0 2 2 2 3
Profit before tax 16 11 31 28 36 60
Tax % 27% 29% 25% 22% 24% 23%
12 8 23 22 27 46
EPS in Rs 12,390.00 8,040.00 84.28 78.00 92.44 14.34
Dividend Payout % 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 20%
3 Years: 8%
TTM: 44%
Compounded Profit Growth
10 Years: %
5 Years: 21%
3 Years: 11%
TTM: 17%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 25%
3 Years: 24%
Last Year: 21%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.01 0.01 3 3 3 32 32
Reserves 38 46 65 86 129 141 162
1 9 21 35 13 84 42
84 70 83 89 125 170 181
Total Liabilities 123 126 172 214 269 427 418
2 2 5 4 22 94 79
CWIP 0 0 0 0 0 0 0
Investments 12 7 17 20 21 15 25
109 116 150 190 226 318 313
Total Assets 123 126 172 214 269 427 418

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
64 -9 -3 -14 60 -36
-28 4 -9 2 -30 -20
-23 6 8 12 -12 36
Net Cash Flow 13 1 -4 -0 18 -20

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 110 135 120 187 156 168
Inventory Days 22 39 17 69 88 119
Days Payable 82 150 136 215 195 198
Cash Conversion Cycle 51 25 1 41 49 89
Working Capital Days -19 15 30 65 63 53
ROCE % 26% 48% 31% 28% 22%

Shareholding Pattern

Numbers in percentages

68 Recently
Oct 2025
68.94%
1.91%
11.63%
17.52%
No. of Shareholders 57,162

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

DRHP

Credit ratings

Concalls